Finding potential biomarkers to predict response to immunotherapy in nonhypermutated

[News]

Scientists have discovered a potential biomarker that could more accurately identify which patients with non-hypermutated cancers will respond to specialized immunotherapy drugs called immune checkpoint inhibitors, according to findings published in Science Translational Medicine.

More... (https://www.news-medical.net/news/20211124/Finding-potential-biomarkers-to-predict-response-to-immunotherapy-in-nonhypermutated-cancers.aspx)